The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Pilot Study To Assess The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Sponsor: Memorial Sloan Kettering Cancer Center
This observational or N/A phase trial investigates Gastro-enteropancreatic Neuroendocrine Tumor and Secondary Malignant Neoplasm of Liver and is currently completed. Memorial Sloan Kettering Cancer Center leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2022 — Feb 2023 [monthly]
Active Not Recruiting
-
Jun 2021 — Jun 2022 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting NA
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .